Insider trade

Eli Lilly (LLY): 10% owner sold ~$3.9M

LILLY ENDOWMENT INC, 10% owner at Eli Lilly, sold ~$3.9M of Eli Lilly shares.

~$3.9M
Approx. value · 3,593 sh @ $1,085.04
92.2M
Holds after · shares reported
Traded
Dec 29, 2025
Filed
Dec 30, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Oct 24, 2025CongressDisclosed purchase of LLY — reported range $1,001 - $15,000
  2. Oct 30, 2025Company filing · Form 8-K · ResultsReported its results
  3. Oct 30, 20255% stakeThe Vanguard Group reported a passive stake (13G) of 8.6%
  4. Oct 30, 20255% stakeLILLY ENDOWMENT, INC. reported a passive stake (13G) of 10.1%
  5. Oct 31, 2025Insider · 1 personInsiders: 8 sales (~$260.2M)
  6. Nov 3, 2025Insider · 1 personInsiders: 24 sales (~$266.6M)
  7. Nov 4, 2025Insider10% owner sold ~$479K of LLY shares in the open market
  8. Nov 5, 2025Insider · 1 personInsiders: 38 sales (~$205.6M)
  9. Nov 10, 2025Insider · 1 personInsiders: 2 sales (~$16.3M)
  10. Nov 11, 2025Insider · 1 personInsiders: 6 sales (~$32.5M)
  11. Nov 18, 2025Company filing · Form 8-K · Executive changeChanged a top executive or board member“On November 18, 2025, the Board of Directors (the “Board”) of Eli Lilly and Company (the “Company”) elected Carolyn R. Bertozzi, Ph.D as a new member of the Board, effective December 8, 2025.”
  12. Nov 20, 2025FDAFDA drug approval: Retevmo
  13. Nov 20, 2025FDAFDA drug approval: Retevmo
  14. Dec 19, 2025FDAFDA drug approval: Mounjaro

What came next

  1. Jan 23, 20265% stakeLILLY ENDOWMENT, INC. reported a passive stake (13G) of 9.8%
  2. Feb 4, 2026Company filing · Form 8-K · ResultsReported its results
  3. Mar 26, 20265% stakeThe Vanguard Group reported a passive stake (13G)
  4. Apr 1, 2026FDAFDA drug approval: Foundayo
  5. Apr 20, 20265% stakeLILLY ENDOWMENT, INC. reported a passive stake (13G) of 9.7%
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Eli Lilly

For Eli Lilly, OQRO holds 4 insider filings (SEC Form 4 or Form 144), 3 Congress trade reports, 5 fund holdings reports (13F) and 1 federal contract award dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its LLY page.

Other recent filings by LILLY ENDOWMENT INC, 10% owner

The full history of LILLY ENDOWMENT INC, 10% owner is on the profile page.

How this filing works

Explore the data

Common questions

Which Eli Lilly (LLY) insider traded, and how much?

LILLY ENDOWMENT INC, 10% owner at Eli Lilly, sold ~$3.9M of Eli Lilly shares. 3,593 shares at $1,085.04.

When did it happen, and when was it made public?

Traded: Dec 29, 2025. Filed: Dec 30, 2025. That is 1 day between the two dates.

Is the dollar amount exact?

It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.

Where does this information come from?

From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Eli Lilly recently?

For Eli Lilly, OQRO holds 4 insider filings (SEC Form 4 or Form 144), 3 Congress trade reports, 5 fund holdings reports (13F) and 1 federal contract award dated in the last 90 days. They are listed on the LLY page.

Does this mean LLY stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Eli Lilly

Everything OQRO holds on this company is on its LLY page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data